CapsoVision, Inc Stock-Based Compensation
CapsoVision, Inc (CV) reported Stock-Based Compensation of $911.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- CapsoVision, Inc share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $577.00K, a 239.41% increase year-over-year.
- CapsoVision, Inc share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $334.00K, a 119.74% increase year-over-year.
- CapsoVision, Inc share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $197.00K, a 74.34% increase year-over-year.
- CapsoVision, Inc share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $307.00K, a 1946.67% increase year-over-year.
- CapsoVision, Inc share-based payment arrangement, noncash expense for fiscal 2025 was $826.00K, a 429.49% increase from fiscal 2024.
- CapsoVision, Inc share-based payment arrangement, noncash expense for fiscal 2024 was $156.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $577.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $911.00K 10-Q · filed 2026-08-13 | $1.11M derived: sum of 3 quarters · filed 2026-08-13 | $1.42M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $334.00K 10-Q · filed 2026-05-14 | $531.00K derived: sum of 2 quarters · filed 2026-05-14 | $838.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.01M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $504.00K derived: sum of 2 quarters · filed 2026-03-26 | $674.00K derived: sum of 3 quarters · filed 2026-08-13 | $826.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $307.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $477.00K derived: sum of 2 quarters · filed 2026-08-13 | $629.00K 10-Q · filed 2025-11-13 | $742.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $322.00K 10-Q · filed 2026-08-13 | $435.00K derived: sum of 3 quarters · filed 2026-08-13 | $450.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $152.00K 10-Q · filed 2026-05-14 | $265.00K derived: sum of 2 quarters · filed 2026-05-14 | $280.00K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $128.00K derived: sum of 2 quarters · filed 2026-03-26 | $156.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $43.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $28.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |